BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026.
World J Hepatol. Jun 27, 2026; 18(6): 120213
Published online Jun 27, 2026. doi: 10.4254/wjh.120213
Table 3 Recurrence risk according to the number of pre-operative risk factors (cirrhosis, albumin-bilirubin grade ≥ 2, Barcelona Clinic Liver Cancer staging system stage B/C)
Number of risk factors
Criteria present
aHR (95%CI)
P value
n (%)
0NoneReferenceReference60 (26)
1Any one of: Cirrhosis, ALBI ≥ 2, or BCLC stage B/C2.74 (1.57-4.76)< 0.001102 (43)
2Any two4.32 (2.29-8.12)< 0.00162 (26)
3All three7.53 (2.47-22.93)< 0.00110 (4)


Write to the Help Desk